MedTrace Logo

The Paracetamol AfteR Traumatic Brain InjurY Study

NCT01231139 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2014-10-28

No results posted yet for this study

Summary

This primary aim is to investigate the effect of paracetamol in reducing body temperature in patients who have sustained traumatic brain injury. This study is also investigating the safety of paracetamol in this patient population.

Conditions

Interventions

DRUG

Paracetamol

Intravenous paracetamol, 1 gram (100mls), administered over 30 minutes (every 4 hours for 3 days).

DRUG

0.9% Sodium Chloride Schedule:

Identical placebo: 100mls saline given intravenous over 30 minutes (every 4 hours for 3 days)

Sponsors & Collaborators

  • The George Institute

    collaborator OTHER

  • The University of New South Wales

    collaborator OTHER

  • Royal Brisbane and Women's Hospital

    collaborator OTHER_GOV

  • Dr. M.K. Saxena

    lead OTHER

Principal Investigators

  • Manoj Saxena · South East Sydney Illawarra Area Health Service

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01231139 on ClinicalTrials.gov